公司资料
Artivion 股价、新闻与催化剂
- 股票代码:
- AORT
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- United States
股票表现
28.32 USD (-2.81%)
收盘价
最后更新: 2026年8月17日
991M USD
市值
股价为何变动
As of Aug 17, 2026, AORT closed down 2.81% at $28.32. No new same-company headline was identified in the current news window.
公司概览
Aortic-Disease Technologies
Artivion develops medical devices and implantable tissues for complex aortic and cardiac surgery. Its portfolio is designed around the needs of cardiac and vascular surgeons treating life-threatening aortic disease.
Surgical Products
The company supplies aortic stent grafts, surgical adhesives, mechanical heart valves and preserved cardiac and vascular tissues. These products support both open and hybrid procedures.
Endovascular Expansion
Artivion exercised its option to acquire Endospan, developer of the FDA-approved NEXUS Aortic Arch System. The transaction would expand Artivion into endovascular treatment of aortic-arch disease alongside its existing surgical portfolio.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。